KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Resmed (RMD) Receivables - Other (2018 - 2025)

Resmed (RMD) has disclosed Receivables - Other for 8 consecutive years, with $61.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other rose 30.61% year-over-year to $61.4 million, compared with a TTM value of $61.4 million through Dec 2025, up 30.61%, and an annual FY2025 reading of $51.2 million, up 34.03% over the prior year.
  • Receivables - Other was $61.4 million for Q4 2025 at Resmed, up from $51.1 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $61.4 million in Q4 2025 and bottomed at $10.9 million in Q2 2021.
  • Average Receivables - Other over 5 years is $34.0 million, with a median of $32.4 million recorded in 2023.
  • The sharpest move saw Receivables - Other surged 169.13% in 2021, then decreased 8.47% in 2022.
  • Year by year, Receivables - Other stood at $24.7 million in 2021, then decreased by 6.37% to $23.1 million in 2022, then soared by 49.62% to $34.6 million in 2023, then surged by 35.98% to $47.0 million in 2024, then surged by 30.61% to $61.4 million in 2025.
  • Business Quant data shows Receivables - Other for RMD at $61.4 million in Q4 2025, $51.1 million in Q3 2025, and $51.2 million in Q2 2025.